Effect of Food of NTQ5082 in Healthy Subjects

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

August 31, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

February 28, 2025

Conditions
Complement-mediated Hemolytic Diseases
Interventions
DRUG

NTQ5082 capsule

"Part 1:The subjects are orally administered NT5082 capsules on an empty stomach in the first cycle and after a meal in the second cycle.~Part 2:The subjects are orally administered NT5082 capsules after a meal in the first cycle and on an empty stomach in the second cycle."

Trial Locations (1)

410035

The Third hospital of Changsha, Changsha

All Listed Sponsors
lead

Nanjing Chia-tai Tianqing Pharmaceutical

INDUSTRY